Table 1 COX regression analysis of risk factors associated with prognosis in patients with colon adenocarcinoma
From: ARL9 is upregulated and serves as a biomarker for a poor prognosis in colon adenocarcinoma
Variable | Univariate analysis | multivariate analysis | ||||
|---|---|---|---|---|---|---|
HR | 95% CI | P value | HR | 95% CI | P value | |
Age, years | 1.0299 | 1.0051–1.0553 | 0.0179 | 1.0430 | 1.0171–1.0695 | 0.0010 |
Sex | 1.1265 | 0.6681–1.8993 | 0.6549 | |||
Stage | 2.5019 | 1.8508–3.3820 | 0.0000 | 1.6395 | 0.6973–3.8548 | 0.2571 |
T stage | 2.9267 | 1.7421–4.9168 | 0.0000 | 1.4600 | 0.7884–2.7036 | 0.2287 |
N stage | 2.1753 | 1.6089–2.9410 | 0.0000 | 1.2611 | 0.7502–2.1198 | 0.3814 |
M stage | 5.2259 | 3.0648–8.9111 | 0.0000 | 1.8926 | 0.5846–6.1277 | 0.2872 |
ARL9 | 1.4412 | 1.1003–1.8877 | 0.0079 | 1.6846 | 1.2666–2.2405 | 0.0003 |